In serum-free mouse osteoblastic MC3T3-E1 cells, basic fibroblastic growth factor (bFGF) induced mRNA and protein for prostaglandin G/H synthase-2 (PGHS-2), the major enzyme in arachidonic acid (AA) conversion to prostaglandins. mRNA accumulation peaked at 1 h with bFGF 1 nM. In cells stably transfected with a 371-bp PGHS-2 promoterluciferase reporter, bFGF stimulated luciferase activity, which peaked at 2-3 h with bFGF 1-10 AM. In the presence of exogenous AA, bFGF stimulated PGE2 production, which paralleled luciferase activity. In serum-free neonatal mouse calvarial cultures, bFGF stimulated PGE2 production in the absence of exogenous AA. bFGF stimulated PGHS-2 mRNA accumulation, which peaked at 2-4 h and then decreased; there were later mRNA elevations at 48 and 96 h that were inhibited by indomethacin. In both MC3T3-E1 cells and neonatal calvariae, bFGF produced smaller and slower increases in PGHS-1 mRNA levels than for PGHS-2. bFGF stimulated bone resorption in mouse calvariae with a maximal increase of 80% at 1 nM. Stimulation was partially inhibited by nonsteroidal anti-inflammatory drugs. We conclude that bFGF rapidly stimulates PGE2 production in osteoblasts, largely through transcriptional regulation of PGHS-2, and that prostaglandins mediate some of bFGF 's effects on bone resorption. (J. Clin. Invest. 1995. 96:923-930.)
Introduction
Basic fibroblast growth factor (bFGF),' a member of the family of heparin-binding growth factors, exerts potent mitogenic activity on a variety of cells of mesodermal and ectodermal origin (1) (2) (3) (4) . Bone cells produce bFGF at 10-fold higher levels than they produce acidic fibroblast growth factor (FGF) another heparin-binding factor that exhibits 55% sequence identity to bFGF (5, 6) . Recently, we found that bFGF mRNA and protein are expressed in mouse osteoblastic MC3T3-E1 cells (7) . bFGF is stored in the extracellular matrix in association with heparin sulfate and is activated by proteases or heparin-like molecules (8) (9) (10) . bFGF could act as an autocrine/paracrine factor for bone cells. bFGF modulates bone formation through the regulation of proliferation and differentiation of cells of osteoblastic lineage in vitro (4) . We have also reported that bFGF stimulates bone resorption in cultured fetal rat long bones (11) .
Among prostaglandins (PGs), PGE2 is the major product of osteoblasts (12, 13) and is a potent bone resorber in vitro (12, 14, 15) . PGE2 also has mitogenic effects on bone cells (16, 17) . Both exogenous bFGF (18) (19) (20) and PGE2 (21) (22) (23) (24) have been shown to stimulate new bone formation in vivo. In some cell lines, including fibroblasts and synovial cells, bFGF has been shown to stimulate PG production (25-27). Therefore, it is possible that some of the effects of bFGF on bone metabolism might be mediated by PG synthesis.
The major enzyme regulating the conversion of arachidonic acid (AA) to PGs is prostaglandin G/H synthase (PGHS), also called cyclooxygenase, which oxidizes AA to PGG2 and reduces PGE2 to PGH2. Two forms of PGHS, constitutive PGHS (PGHS-1) and inducible PGHS (PGHS-2), have been identified. PGHS-l mRNA has been identified in many ovine, murine, and human tissues (28), while the PGHS-2 mRNA was first found as an immediate-early gene from murine fibroblasts and chick embryo fibroblasts (29) (30) (31) . These two enzymes have 60% homology in nucleic acid and amino acid sequence, although they are products of separate genes (28). Both are glycoproteins whose molecular weight is 70-74 kD. PGHS-1 is constitutively expressed, while the recently identified PGHS-2 is likely to be more important in regulating prostaglandin production by extracellular ligands. Both PGHS-1 and PGHS-2 are expressed in osteoblastic cells. PGHS-2 is the main enzyme regulating the production of PGE2 in response to hormones and cytokines in MC3T3-E1 cell cultures and neonatal mouse calvarial cultures (32-34).
The present study was undertaken to examine the effects of bFGF on PG production and the role of PGs in the response to bFGF in bone. Mouse osteoblastic MC3T3-E1 cells were used to investigate the cellular mechanisms by which bFGF regulates PG synthesis, and neonatal mouse calvarial cultures were used to examine the involvement of PGs in bFGF-stimulated bone resorption.
(P2-Luc963 or P2-Luc371, respectively) have been described previously (35 Western blot analysis. MC3T3-E1 cells were plated in 100-mm dishes (Costar Corp.) at a density of 5,000 cells/cm2 and grown to confluence in DME containing 10% serum. Cells were serum deprived for 24 h and treated for 2, 6, and 24 h with or without bFGF (10 nM). Cells were then washed with PBS, harvested by centrifugation, and extracted with 0.5% Tween 20 in a 20 mM potassium phosphate buffer (pH 7.4) containing 1 mM phenylmethyl-sulfonyl fluoride, 1 mM EDTA, and 1 mM N-ethylmaleimide at 4°C for 30 min. This mixture was centrifuged at 14,000 g for 30 min. The supernatant was dialyzed against N-ethylmaleimide without Tween 20 for 16 h, and an aliquot was mixed with DEAE cellulose (200-ul bed volume/mg protein) preequilibrated with the potassium phosphate buffer containing 0.05% Tween 20. DEAE cellulose was precipitated by centrifugation, and protein in the supernatant was measured by the BCA protein assay kit (Pierce). 25 gg of protein per treatment group was run on an SDSpolyacrylamide gel (10%) and transferred to a polyvinylidene difluoride membrane. Membranes were incubated with 1% nonfat dry milk at 4°C for 16 h to block nonspecific binding and then treated with a 1:2,000 dilution of polyclonal rabbit anti-PGHS-2 antiserum or nonimmune rabbit serum. Immunoreactive bands were stained using a Western exposure chemiluminescent detection kit (Clontech) according to the manufacturer's instructions.
Immunocytochemistry. MC3T3-E1 cells were plated on glass coverslips at a density of 5,000 cells/cm2 and grown in DME with 10%
FCS. When at least 80% confluent, cells were serum deprived for 24 h and then cultured for 6 or 24 h with or without bFGF (10 nM). Cells were fixed with 2% paraformaldehyde in PBS for 30 min at room temperature. Cells were rinsed twice for 10 min with PBS. Cells were permeabilized with 0.1% Triton X-100 for 20 min on ice (37) . After a 20-min incubation with 0.1% gelatin in PBS, a 1:40 dilution of the rabbit anti-murine PGHS-2 antiserum or rabbit nonimmune serum was added to cells for 2 h at room temperature. A 1:200 dilution of rhodamine-conjugated anti-rabbit IgG was added to the cells for 1 h at room temperature. To prevent quenching of the fluorescence, 2.5% n-propyl gallate in 1:1 PBS:glycerol was added. The cells were photographed with a fluorescence microscope (Optiphot; Nikon Inc., Melville, NY).
PGE2 assays. Medium was removed from cultured cells or bones, and PGE2 accumulation was measured by radioimmunoassay as described previously (38) . In some instances indicated in the text, AA (10 pM) was added to MC3T3-E1 cell culture to provide substrate for PGE2 production.
Statistical analysis. Means of groups were compared using ANOVA, and significance of differences was determined by post-hoc testing using Bonferroni's method.
Results
PGHS-2 mRNA was undetectable in unstimulated MC3T3-E1 cells, but was rapidly induced by bFGF (10 nM). mRNA levels TIME (H) 0 0.5 (Fig. 4) . Immunoreactive protein was induced by bFGF (10 nM) at 2 h and was still present at 24 h. Multiple bands were present at 24 h, perhaps due to deglycosylation during culture (39) . The localization of PGHS-2 protein was examined by immunocytochemistry at 6 and 24 h of culture ( (Fig. 8 B) . (33), we examined the effects of two structurally unrelated nonsteroid anti-inflammatory drugs (NSAIDs) indomethacin and flubiprofen (both at 1 MLM) on the induction of PGHS-2 in mouse calvariae cultures by bFGF (Fig. 9) . At 4 h the induction was only slightly inhibited. At 48 and 96 h, both NSAIDs inhibited the bFGF induction of PGHS-2 mRNA accumulation by about 80%, suggesting that the recurrence of PGHS-2 induction at later time points was probably due to autoamplification by the production of prostaglandins.
Both bFGF and PGE2 can have potent effects on osteoblastic proliferation and synthesis of collagen. We have previously reported that bFGF inhibited collagen synthesis in MC3T3-E1 cells but that this inhibition was not PG dependent (42) . In the present study, we examined the effect of bFGF (10 nM) on (Table H) . However, APC alone increased PGE2 production and bone resorption; both effects were blocked by indomethacin (Table II) . Therefore, we added both APC and indomethacin and found that the combination abrogated the effects of bFGF on bone resorption. (43, 44) . However, maintaining the bFGF induction of pPGHS-2 mRNA in the presence of cycloheximide suggests that the major effect of bFGF is to directly activate one or more transcription factors. Other putative consensus sequences identified within this region include an SP-1 site, an ATF/CRE region, and an E-box or helix-loop-helix protein-binding element. The ATF/CRE site has been recently shown to mediate v-src induction of the murine PGHS-2 promoter (45) .
Basic FGF also rapidly stimulated PGHS-2 mRNA levels in neonatal mouse calvarial cultures. Basic FGF increased medium PGE2 levels in these cultures, which were measurable in the absence of exogenous substrate, and stimulation of PGE2 production paralleled the stimulation of PGHS-2 mRNA expression. The mitogenic effects of bFGF in MC3T3-El cells and the inhibitory effects of bFGF on collagen synthesis in MC3T3-El cells (42) have been shown to be independent of PG production. However, in the present study, the inhibition of PG production by NSAIDs reduced bFGF-stimulated resorption in neonatal mouse calvariae, indicating that the resorptive effect of bFGF was mediated in part by PGs. Although an inhibitor of DNA synthesis alone did not block PG-mediated resorption, inhibition of both DNA synthesis and PG production completely blocked bFGF-stimulated resorption. Hence, we propose that bFGF has a direct effect on resorption through stimulation of proliferation of osteoclast precursors and an indirect effect mediated by PGs. We have shown by histological examination that bFGF increases the number of osteoclast-like cells in cultures of 21-d fetal rat calvariae (46) . In a previous study in cultured fetal rat long bones, we found that bFGF-stimulated bone resorption was independent of PGs ( 11 ) . Many stimulators of resorption show different degrees of dependence on endogenous prostaglandin production in different model systems, and even in the same model systems. In general, endogenous prostaglandin production is more likely to play a role in resorptive responses in neonatal mouse calvariae than in fetal rat long bones. Similar observations have been made for thyroid hormone (47) and interleukin 1 (48, 49 ). These differences may reflect the fact that the two culture systems contain a different population of osteoclast precursor cells or differences in other cell populations, particularly since the neonatal mouse calvariae contain some hematopoetic marrow, while fetal rat long bones do not.
Although the induction of PGHS-2 mRNA by bFGF in calvarial cultures had decayed by 24 h, there was a rebound induction at 48 and 96 h. This rebound could be inhibited by treatment with NSAIDs and hence was probably due largely to autoamplification by endogenous PGs. Autoamplification, perhaps in conjunction with the smaller, slower, but more sustained increases in PGHS-l expression, may play an important role in maintaining physiologic responses mediated by PGs, such as bFGFstimulated resorption, which are initiated by transient inductions of PGHS-2 expression.
